-
Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
24 Apr 2024 12:14 GMT
… research, collaborations, clinical trials and expected goals for the drug or AI … future of the Harmonic™ Phase 2 clinical trial for LP-300 in never … Pharma on the LP-184 clinical trial. Dr. Astsaturov is an … to first-in-human clinical trials in 2-3 years …
-
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
24 Apr 2024 11:47 GMT
… for the DMT Phase 1 clinical trial, will present “Safety, … is a hallucinogenic tryptamine drug producing effects similar to … to advance into a Phase 2 study was based on … clinical stage drug development company investigating multiple drugs for unmet …
-
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
24 Apr 2024 10:47 GMT
… GLP-1 drugs like Wegovy and Ozempic. Phase 2 data regarding … clinical trials. One of the pills is a GLP-1 drug … combination with GLP-1 drugs. That drug is expected to improve … wasting associated with GLP-1 drug administration.
Additionally, Structure …
-
Hepion shelves Phase II NASH trial amid shallow cash resources
23 Apr 2024 20:28 GMT
Hepion Pharmaceuticals has called it quits on a Phase IIb trial investigating the biotech’s lead drug candidate for the treatment of non-alcoholic steatohepatitis (NASH).
The US company, which uses artificial intelligence and deep machine learning to …
-
PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
23 Apr 2024 12:00 GMT
… from its VERSATILE-002 Phase 2 clinical trial with Versamune® HPV in … IL-12 fused antibody drug conjugate PDS01ADC may … IL-12 fused antibody drug conjugate (ADC) PDS01ADC … Company’s ongoing clinical trials and anticipated clinical trials for the Company …
-
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after UCLA-led research shows improved outcomes for patients
24 Apr 2024 04:05 GMT
… has approved the immunotherapy-boosting drug N-803, which is marketed … of the QUILT 3.032 clinical trial, which was led by Dr … Cancer Center.
Findings from the phase 2/3 trial were presented … the addition of the investigational drug N-803 to the treatment …
-
Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
23 Apr 2024 09:56 GMT
… not-for-profit research organization Drugs for Neglected Diseases initiative (DNDi … endemic country, is conducting a Phase II clinical trial on a new chemical entity … the European and Developing Countries Clinical Trials Partnership (EDCTP2) through grant …
-
Global Clinical Trials Market Analysis, Size, and Forecasts 2023 and 2024-2030 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, Sanofi, and Medpace - ResearchAndMarkets.com
23 Apr 2024 15:09 GMT
… clinical trials
The global clinical trials market is split into phases: Phase 1, Phase 2 … 0% of the investigational drugs are usually in phase II trials. Furthermore, … to dominate the clinical trial market. The requirement for clinical trials to improve …
-
Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
23 Apr 2024 12:57 GMT
… from its Phase 1b clinical trial evaluating the safety and … gain (AIWG) is a drug-induced epidemic within the already … RDX-002.”
The planned Phase 2 clinical trial of RDX-002 will be … multiple Phase 1 and Phase 2 clinical trials including 496 healthy subjects …
-
Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting
23 Apr 2024 12:00 GMT
… from the Company’s Phase 2 RIZE study evaluating the … RZ358 also received orphan drug and pediatric rare disease … in the Company’s drug development process. Rezolute places … hyperinsulinism, and statements regarding clinical trial timelines for RZ358. Our …